Start Codon, One Nucleus Partner to Support Start-Ups in Accelerator Program
Life science and healthcare business accelerator, Start Codon, and membership organization, One Nucleus, have partnered up to support the life science ecosystem in the United Kingdom.
Life science and healthcare business accelerator, Start Codon, and membership organization, One Nucleus, have partnered up to support the life science ecosystem in the United Kingdom, it was revealed in a Dec. 11, 2019 press release.
Under the terms of the partnership, One Nucleus will support and profile the life science and healthcare start-up companies that are taking part in the Start Codon accelerator program. The partnership will commence on Jan. 6, 2020 and will see One Nucleus provide Start Codon cohort companies with gold membership benefits for a 12-month period.
“Like Start Codon, One Nucleus is committed to playing an active and supportive role in enabling the success of the UK life science cluster, particularly that in the East of England and London,” said Dr. Jason Mellad, CEO at Start Codon, in the press release. “Having One Nucleus membership benefits will be extremely valuable to our cohort, particularly for developing a network of industry leading contacts.”
Tony Jones, CEO at One Nucleus, added, “One Nucleus can provide local, UK-wide and international connectivity to enable companies to maximise their performance within the life sciences and healthcare industry. Therefore, we are excited to partner with Start Codon to help facilitate the next generation of innovative and entrepreneurial companies.”
Source: Start Codon
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
